^
CANCER:

Adenoid Cystic Carcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
MYB underexpression
Adenoid Cystic Carcinoma
tretinoin
Sensitive
:
C3
NOTCH1 mutation
Adenoid Cystic Carcinoma
tretinoin
Sensitive
:
C3
NOTCH mutation
Adenoid Cystic Carcinoma
AL101
Sensitive
:
C3
NOTCH1 positive + FGFR2 mutation
Adenoid Cystic Carcinoma
lenvatinib + erdafitinib + γ-secretase inhibitor
Sensitive
:
C4
MYB-NFIB fusion + BCOR F1106Tfs*5 + BCOR L1524Hfs*8
Adenoid Cystic Carcinoma
anlotinib + eribulin mesylate
Sensitive
:
C4
BCOR L1524Hfs*8
Adenoid Cystic Carcinoma
anlotinib
Sensitive
:
C4
BCOR F1106Tfs*5
Adenoid Cystic Carcinoma
anlotinib
Sensitive
:
C4
MYB-NFIB fusion
Adenoid Cystic Carcinoma
M6620
Sensitive
:
D
PIK3CA mutation
Adenoid Cystic Carcinoma
PI3K inhibitor
Sensitive
:
D
MYB fusion + PIK3CA mutation
Adenoid Cystic Carcinoma
PI3K inhibitor
Sensitive
:
D
AXL overexpression
Adenoid Cystic Carcinoma
ADCT-601
Sensitive
:
D